EUVIMEDEUVIMED entdecken
Crossref

Integrating Seropharmacology, Network Pharmacology, and Single‐Cell Transcriptomics to Decipher the Dual Anti‐Tumor Mechanisms of Astragalus– Curcuma zedoaria in Lung Squamous Cell Carcinoma

Luhang Yu, Xueshan Dong, Qianyu Yang, Yongqi Dou

Biomedical Chromatography · 2026-07 · 40 (7)

DOI: 10.1002/bmc.70482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 09.06.2026. Verfasst von Luhang Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Astragalus Plant, Lung Neoplasms, Carcinoma, Squamous Cell, Curcuma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study sought to elucidate the antitumor mechanisms of the traditional herbal combination Astragalus– Curcuma zedoaria (A–C) in lung squamous cell carcinoma (LUSC). Drug‐containing serum was prepared from mice administered an A–C decoction, and serum‐absorbed bioactive components were identified using high‐resolution mass spectrometry. To investigate potential targets and pathways within the tumor immune microenvironment, network pharmacology analysis was integrated with bulk transcriptomic data from TCGA‐LUSC and single‐cell RNA sequencing (scRNA‐seq). The analytical methodologies employed included differential gene expression analysis, weighted gene co‐expression network analysis (WGCNA), functional enrichment analysis, and molecular docking. The scRNA‐seq data identified 22 distinct cell clusters, with correlation analysis suggesting that A–C primarily exerts its effects through vascular endothelial cells. Among the serum‐derived components, demethoxycurcumin—a principal curcuminoid from C. zedoaria —demonstrated the highest binding affinity with the TEK receptor tyrosine kinase (−7.5 kcal/mol), indicating its potential role in modulating endothelial function and vascular–immune interactions. In conclusion, the A–C combination exhibits a synergistic effect in lung squamous cell carcinoma (LUSC) by modulating differentially expressed genes, with demethoxycurcumin identified as a pivotal bioactive compound targeting TEK. These results elucidate novel dual antitumor mechanisms of the A–C herbal pair, achieved through the regulation of the vascular–immune microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Astragalus PlantLung NeoplasmsCarcinoma, Squamous CellCurcumaDrugs, Chinese HerbalPlant ExtractsAnimalsMiceNetwork PharmacologyHumansMolecular Docking SimulationSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisTranscriptomeCell Line, TumorMale

Stichwörter der Autor:innen

Curcuma zedoariaAstragalusTEKdemethoxycurcumindrug‐containing serumlung squamous cell carcinoma (LUSC)molecular dockingsingle‐cell RNA sequencing

Substanzen

Drugs, Chinese HerbalPlant Extracts

Autor:innen und Institutionen

  • Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
  • Department of Oncology, Beijing Chaoyang Intergrative Medicine Rescue and First Aid Hospital, Beijing, China.
  • Department of Traditional Chinese Medicine, The Ninth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Department of Traditional Chinese Medicine, The Sixth Medical Center, General Hospital of Chinese PLA, Beijing, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yu, L., Dong, X., Yang, Q., & Dou, Y. (2026). Integrating Seropharmacology, Network Pharmacology, and Single‐Cell Transcriptomics to Decipher the Dual Anti‐Tumor Mechanisms of Astragalus– Curcuma zedoaria in Lung Squamous Cell Carcinoma. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70482

Vancouver

Yu L, Dong X, Yang Q, Dou Y. Integrating Seropharmacology, Network Pharmacology, and Single‐Cell Transcriptomics to Decipher the Dual Anti‐Tumor Mechanisms of Astragalus– Curcuma zedoaria in Lung Squamous Cell Carcinoma. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70482

BibTeX
@article{Yu2026,
  author = {Yu, Luhang and Dong, Xueshan and Yang, Qianyu and Dou, Yongqi},
  title = {Integrating Seropharmacology, Network Pharmacology, and Single‐Cell Transcriptomics to Decipher the Dual Anti‐Tumor Mechanisms of Astragalus– Curcuma zedoaria in Lung Squamous Cell Carcinoma},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1002/bmc.70482}
}
Kostenlos starten →